Skip to content

Clinical trials

Glucose Intolerance trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glucose Intolerance Phase: Not applicable Country / region: United States Clear all

214 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20053
20063
20073
20085
20097
20105
201110
201210
20135
201411
20155
201614
201710
201814
201914
20205
202116
202222
202311
202415
202511
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed146
Recruiting20
Active, not recruiting17
Unknown status10
Withdrawn8
Terminated6
Not yet recruiting3
Enrolling by invitation3
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Clinical Nutrition Research Center, Illinois Institute of Technology8
Johns Hopkins University8
University of California, Los Angeles7
Emory University5
Pennington Biomedical Research Center5
University of Michigan5
NYU Langone Health4
Purdue University4
Stanford University4
Wake Forest University Health Sciences4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glucose Intolerance214
Obesity63
Diabetes Mellitus41
Diabetes Mellitus, Type 238
Insulin Resistance38
Prediabetic State31
Overweight26
Metabolic Syndrome24
Hypertension15
Weight Loss10

Trials

Showing 1 to 25 of 214. Each trial links to its page on Pharma Observatory.

114 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.